2018•Annals of Nuclear MedicineRequires access

The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms

Terje Løitegård, Dag Tallak Kjærsdalen Berntzen, Espen Thiis‐Evensen

Open publisher page 9 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Response Evaluation Criteria in Solid Tumors, Radionuclide therapy, Progressive disease, Radiological weapon, Neuroendocrine tumors, Peptide receptor, Radiology

Back to paper search Browse research topics Original source

The RECIST criteria compared to conventional response evaluation after peptide receptor radionuclide therapy in patients with neuroendocrine neoplasms — Research Paper | ScholarLens